USD 40.69 billion
Global Peptide Therapeutics Market Size, Share, Growth Analysis, By Application(Cancer, Metabolic), By Type of Manufacturers(In-house, Outsourced), By Type(Generic, Innovative), By Route of Administration(Parenteral, Oral), By Synthesis Technology(Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS)) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2072 |
Region:
Global |
Published Date: February, 2024
Pages:
213
|
Tables:
152 |
Figures:
78
Global Peptide Therapeutics Market Insights
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
The acceptability of peptide therapies will be impacted by the rise in cancer cases as well as metabolic illnesses like osteoporosis, obesity, and diabetes. Due to the sheer increase in the number of pediatric kids affected and the frequency of the target diseases in low-income countries, there is a tremendous demand for efficient and affordable treatments.
Advanced peptides are now being developed and modified for the treatment COVID-19. Researchers from all over the world are hunting for substances that either alleviate the circumstances brought on by infection or stop the mechanisms involved in severe acute respiratory infection and replication. On February 21, 2020, the Food and Drug Administration revised its definition of a biologic to include synthetic peptides with 40 amino acids or fewer and chemically produced polypeptides larger than 40 amino acids but smaller than 100 amino acids. Due to the fact that peptide medications are now being considered as a possible COVID-19 treatment, COVID-19 may have a significant impact on the market.
US Peptide Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Innovative
Fastest Growth
Innovative
Growth Rate
5.94% CAGR
Global Peptide Therapeutics Market ($ Bn)
Country Share for Asia Pacific Region (%)
Global Peptide Therapeutics Market By Type ($ Bn)
Global Peptide Therapeutics Market By Type (%)
To get more reports on the above market click here to Buy The Report
Global Peptide Therapeutics Market Segmental Analysis
Global peptide therapeutics market is segmented on the basis of application, type, type of manufacturers, route of administration, synthesis technology, and region. By application, the market is segmented into cancer, metabolic, cardiovascular disorder, respiratory, GIT, anti-infection, pain, dermatology, CNS, renal, and others. By type, the market is segmented into generic and innovative. By type of manufacturers, the market is segmented into in-house and outsourced. By route of administration, the market is segmented into parental, oral, pulmonary, mucosal, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Peptide Therapeutics Market Analysis by Type
The innovative sector dominated the market in 2021 with a highest revenue share owing to rising R&D expenditures by major pharmaceutical companies in the research and development of new pharmaceuticals as well as high prescription rates. Based on kind, the market is split into generic and cutting-edge categories.
Throughout the projected period, the generic segment is anticipated to expand quickly. The adoption of generic drugs is anticipated to be fueled by rising healthcare costs and increased federal government healthcare spending. It is also thought that a major factor propelling the generic category is the loss of patent protection for many branded medications. The expiration of a patent is seen as a big chance for generic companies to join the market with less expensive versions of popular medications. Brand loyalty, however, may affect sector growth in the case of some novel medications.
Global Peptide Therapeutics Market By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Peptide Therapeutics Market Regional Insights
The peptide therapeutics market was dominated by North America in 2021. The rise of the regional market is primarily attributed to the expansion of the biotechnology industry, increasing demand for cancer and other disease diagnostics, and expanding consumer awareness of peptide treatment products. Additionally, it is projected that increased government spending on R&D will support peptide treatments' continued supremacy over the forecast period. The region's well-established biotech and pharmaceutical sectors are a major contributor to the expansion. According to the American Cancer Society, 1.9 million more cancer cases are expected in the United States in 2022. Cancer is the second most common cause of death in the country, behind heart disease.
Global Peptide Therapeutics Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Peptide Therapeutics Market Dynamics
Peptide Therapeutics Market Drivers
Increased Usage of Peptide in Cancer Treatment to Bolster Market
- Due to their high specificity, discernment, tiny sizes, simplicity of modification, and high biocompatibility, peptide therapies are used as targets in the administration of anti-cancer medications. The segment is expanding due to elements like the rising cancer burden, new launches, and research and development.
- The main causes of this market's domination are the rising incidence of cancer worldwide and the rising prescription of peptide therapies for cancer therapy. For instance, according to data from the American Cancer Society's Cancer Facts & Figures 2022 report, the US registered 1.9 million new cancer cases in 2022. Therefore, it is anticipated that the increasing frequency of cancer cases throughout the world would significantly contribute to the study segment's growth throughout the forecast period.
Peptide Therapeutics Market Restraints
Expensive Developing Drugs to Hinder Market
- The global market is expected to rise, although this is anticipated to be constrained by the high cost of peptide drug research and development. The discovery and production of peptide medications are governed by strict government regulations, which is seen to be one of the main factors limiting the market's expansion for peptide treatments. Additionally, the potential of adverse effects brought on by long-term peptide medication use provides a barrier to market expansion.
Request Free Customization of this report to help us to meet your business objectives.
Global Peptide Therapeutics Market Competitive Landscape
Technology innovations and the development of new products are important techniques used by companies to acquire market share. Additionally, it is predicted that growing alliances for conducting new drug trials will enhance rivalry in the industry. For instance, Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced a new agreement in May 2022, according to which Pfizer will procure Biohaven, the producer of NURTEC ODT, an advanced dual-acting migraine therapy approved for both acute treatments and episodic migraine prevention in adults. The key market players involved in the manufacture of automotive gears includes;
Peptide Therapeutics Market Top Player’s Company Profiles
- Amgen, Inc.
- AstraZeneca plc
- Bachem Holding AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Ipsen S.A.
- Merck & Co., Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Lonza Group AG
- Ferring Pharmaceuticals, Inc.
- PolyPeptide Group
- Protagonist Therapeutics, Inc.
- Ipsen Biopharmaceuticals, Inc.
- Polytherapeutics Inc.
- Zealand Pharma A/S
Peptide Therapeutics Market Recent Developments
- In 2022, A multi-year research partnership and license agreement between Amgen and Plexium, Inc. is intended to provide new targeted protein degradation therapies for challenging pharmacological targets. By utilizing Amgen's expertise in developing multispecific compounds, the multiyear alliance will support the development of novel molecular glue therapies.
- In 2021, For a variety of unfulfilled healthcare needs of the public, ISSAR Pharmaceuticals opted to license out its peptide-based unique chemical compounds with pre-IND filing and a U.S. Patent in an effort to make it accessible and inexpensive for improved outcomes.
Global Peptide Therapeutics Key Market Trends
- The majority of peptide medications are currently given through the parenteral route, and about 75% are given as injectables. However, in accordance with the corresponding technological advancements, alternate administration modalities, including as oral, intranasal, and transdermal delivery routes, are gaining more and more popularity.
- Future peptide medication development will build on the advantages of naturally occurring peptides while overcoming their limitations, such as their chemical and physical properties, through the use of conventional rational design.
Global Peptide Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global peptide therapeutics market analysis, peptide medicine research has advanced significantly in recent years due to advances in production, modification, and analytical technologies. The fundamental limitations of peptides have been removed, which has allowed for market expansion. Due to the adoption of a modern and unhealthy lifestyle, there is a clear rising trend in metabolic illnesses including diabetes and obesity as well as an increase in cardiovascular diseases and cancer. The market opportunity for peptide therapies is therefore driven by the aforementioned factors.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 40.69 billion |
| Market size value in 2031 | USD 68.4 billion |
| Growth Rate | 5.94% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
| Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Peptide Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Peptide Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Peptide Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Peptide Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Peptide Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Peptide Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Peptide Therapeutics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 617-230-0741
